Get access

Antioxidant supplements for liver diseases

  • Protocol
  • Intervention

Authors

  • Goran Bjelakovic,

    Corresponding author
    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    • Goran Bjelakovic, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. goranb@junis.ni.ac.yu.

    Search for more papers by this author
  • Dimitrinka Nikolova,

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author
  • Lise Lotte Gluud,

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author
  • Marija Bjelakovic,

    1. Medical Faculty, University of Nis, Institute of Anatomy, Nis, Serbia
    Search for more papers by this author
  • Aleksandar Nagorni,

    1. Medical Faculty, University of Nis, Department of Internal Medicine - Gastroenterology and Hepatology, Nis, Serbia
    Search for more papers by this author
  • Christian Gluud

    1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of the antioxidant supplements beta-carotene, vitamin A, vitamin C, vitamin E, and selenium for treatment of acute and chronic liver disease, apart from non-alcoholic fatty liver disease, which is dealt with in another Cochrane Hepato-Biliary Group Review (Lirussi 2007).

Ancillary